Not social, just media

Citizen journalism user generated content social media

It’s not social media anymore, it’s ‘high-impact eyewitness media’.

That’s according to the Associated Press (AP), which earlier this month outlined how it would augment its newswire services with user-generated social media content.

The AP Social Newswire will provide a feed of social media posts that have been vetted and verified by AP editors, adding a new element to the collaboration it’s had since 2015 with social media monitoring platform SAM, in which it’s also takend an equity stake. Read the rest of this entry »

Advertisements

, , , , ,

Leave a comment

Digital music roundup: Spotify, US streaming market, Samsung music, Neil Young and Gorillaz

Gorillaz

In this digital music roundup – the first in a possible series: Spotify’s paywall, the US streaming market, Samsung and Google Play Music, Neil Young’s new streaming service Xstream and two augmented reality apps from Gorillaz (pictured above)

Spotify will allow labels to put new albums behind a two-week ‘paywall’, during which time they will only be available to the streaming service’s paying users. It concluded separate deals with digital rights agency Merlin, which negotiates on behalf of thousands of indies – including Sub Pop, Epitaph and Domino, and Universal Music Group (UMG). The flexible release policy also provides “unprecedented access to data, creating the foundation for new tools for artists and labels to expand, engage and build deeper connections with their fans”. Read the rest of this entry »

, , , , , , , , ,

Leave a comment

A marathon, not a sprint

PME Pharmaceutical Market Europe April 2017

The delivery of Theresa May’s letter to European Council president Donald Tusk triggering Article 50, and the official start of the UK’s two-year process of negotiating its divorce from the EU, made the choice of this month’s PME cover an easy one.

Inside the issue there’s a great look at the implications of Brexit for pharma, with Nicola Maguire from law firm Cooley LLP rounding up the industry’s areas of concern, Alexa Forbes from Four health Communications asks ‘can UK pharma rise to the post-Brexit challenge’ and greyhealth group’s Paul Hughes looks at the facts (and the alternative facts) of the situation.

Meanwhile, in a series of exclusive interviews with PME, Japanese pharmaceutical companies pull no punches when it comes to what the reassurance they want from the UK on its future in science and innovation. Read the rest of this entry »

, , , , ,

Leave a comment

Slower speeds for faster growth as online firms continue adapting to India’s mobile market

World Bank cellphone mobile India

Community meeting in Aurangabad, India (Pic: World Bank)

To describe the growth of the internet in India as explosive probably downplays the rate of change taking place.

Every second three more Indians come online for the first time, adding another 10,000 people every hour to the country’s online user base.

So it’s no surprise that internet firms – particularly those of a social nature – are working hard to overcome barriers to access that range from low-powered phones to 2G connections to very little data. Read the rest of this entry »

, , , , , , , , , ,

Leave a comment

A cheery tale on the darker side of business travel

London view sky above aeroplane

Travelling for work can certainly be fun as you jet off to cities you might not otherwise visit, but it’s not always quite as glamorous as friends and family believe.

It can also be a bit of a slog, particularly when you find yourself on a day trip to from London to Frankfurt, Geneva, Basel or Paris (delete as appropriate). And that’s before flights are delayed, luggage gets lost and so on.

None of this will be news to those that travel frequently for business. Neither perhaps will be the personal and social consequences, as illustrated by the University of Surrey’s 2015 study A Darker Side of Hypermobility. Read the rest of this entry »

, ,

Leave a comment

Employee engagement and nurturing talent in pharma

PME Pharmaceutical Market Europe March 2017

You won’t generally find PME issues following a particular theme each month – there’s simply too much interesting ground to cover in the magazine for that.

Nevertheless, as each issue coalesces there are often common strands across different features and such seemed the case with March’s PME, which contains a nice chunk of ‘careers’ content.  Read the rest of this entry »

, , , , , , , , ,

Leave a comment

Looking like a true survivor?

Untitled

Predictions of the death of print have been around for while, but there’s nothing like walking into a really well-stocked newsagents to make you consider the medium anew.

As newspapers like the New York Times take a leaf out of the magazine playbook and indie-published titles flourish, it’s no wonder there are suggestions 2017 could mark another turning point in print’s fortunes. Read the rest of this entry »

, ,

Leave a comment

%d bloggers like this: